Cargando…
Hereditary angioedema C1-inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
Background: Autoimmune diseases are a leading cause of morbidity and mortality in the US (estimated prevalence: 4.5%) and often associated with dysregulation of the complement system (innate and adaptive immune response). The classic complement pathway is regulated by the C1-inhibitor (C1-INH), whic...
Autores principales: | Farkas, Henriette, Fridman, Moshe, Supina, Dylan, Chiao, Joseph, Prusty, Subhransu, Berger, Melvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764354/ http://dx.doi.org/10.1080/21556660.2019.1658292 |
Ejemplares similares
-
Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
por: Farkas, Henriette, et al.
Publicado: (2020) -
The symptom experience of hereditary angioedema (HAE) patients beyond HAE attacks: literature review and clinician interviews
por: Jean-Baptiste, Milenka, et al.
Publicado: (2022) -
Patterns of on-demand medication use in patients with hereditary angioedema treated long-term with prophylactic subcutaneous C1-inhibitor
por: Levy, Donald S., et al.
Publicado: (2019) -
Management of upper airway edema caused by hereditary angioedema
por: Farkas, Henriette
Publicado: (2010) -
Pediatric hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette
Publicado: (2010)